Published Technical Disclosure Archive

Nanoporous Canister Technology for Environmental and Agricultural Applications

Publication ID: 24-11857672_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Nanoporous Canister Technology for Environmental and Agricultural Applications,” Published Technical Disclosure No. 24-11857672_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857672_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,672.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of the original implantable cellular and biotherapeutic agent delivery canister to develop novel applications in environmental monitoring, agricultural pest control, cosmetics and skincare, bioremediation, and food safety monitoring.

Background and Problem Solved

The original patent's limitations were primarily focused on medical applications. However, the nanoporous canister technology has untapped potential in addressing pressing environmental and agricultural challenges. The inventive concept tackles the specific problem of developing sustainable, controlled-release solutions for pollutant detection, pest control, skin regeneration, bioremediation, and food safety monitoring.

Detailed Description of the Inventive Concept

The new inventive concept comprises nanoporous canisters containing metabolically active biotherapeutic agents or microorganisms, designed to detect and respond to pollutants in water or air, control agricultural pests, promote skin regeneration and rejuvenation, break down pollutants in soil or groundwater, and detect foodborne pathogens. The canisters' nanoporous structure and surface treatment pattern enable controlled release of the agents, ensuring optimal performance and minimizing environmental impact.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the original patent's technology to entirely new industries, providing a non-obvious solution to pressing environmental and agricultural challenges. The inventive concept's novelty lies in the adaptation of the nanoporous canister technology to address specific problems in these new fields.

Alternative Embodiments and Variations

Alternative embodiments may include varying the nanoporous structure's material, size, and shape to optimize performance in different environmental or agricultural settings. Variations may also involve combining multiple biotherapeutic agents or microorganisms to tackle complex problems or integrating the canisters with existing monitoring systems or agricultural equipment.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the environmental monitoring, agricultural, cosmetics, bioremediation, and food safety industries. The market demand for sustainable, controlled-release solutions is growing, driven by increasing concerns about environmental pollution, food security, and human health.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61F2/022
A A61 A61K31/337
A A61 A61K31/397
A A61 A61K31/436
A A61 A61K31/65
A A61 A61K31/7036
A A61 A61K35/28
A A61 A61K38/14
A A61 A61K38/1866
A A61 A61K38/22
A A61 A61K39/395
A A61 A61K47/02
A A61 A61M39/0247
A A61 A61M2039/027
A A61 A61M2039/0261
A A61 A61M2039/0276
A A61 A61M2205/04

Field of Art

Biomedical engineering, specifically nanoporous medical device design, drug delivery systems, and biotechnology applications with expertise in materials science, microencapsulation, and controlled release technologies

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in bioengineering, materials science, or related fields, possessing knowledge of nanoscale fabrication techniques, biomaterial interactions, and interdisciplinary applications of controlled release technologies

Obviousness Rationale

A PHOSITA would recognize that the nanoporous canister technology's fundamental principles of controlled agent release and surface treatment are readily adaptable across multiple domains. The source patent's core innovation of a nanoporous structure for encapsulating and strategically releasing biological agents provides a clear technological framework that can be systematically extended to environmental, agricultural, and diagnostic applications. The PTD's variations represent predictable engineering adaptations that leverage the established technological principles disclosed in the original patent.

Obvious Combinations & Variations

Source Patent Element
Nanoscale through-porous structure with surface treatment pattern for controlled agent exposure
PTD Variation
Applying the nanoporous structure to environmental monitoring and pollutant detection systems
Obviousness Reasoning
A PHOSITA would recognize that the controlled release mechanism is directly transferable to sensing and response technologies, representing a known technique for adapting drug delivery principles to detection applications
Source Patent Element
Implantable device designed for isolating and releasing therapeutic agents
PTD Variation
Utilizing nanoporous canisters for agricultural pest control by containing species-specific toxin-producing agents
Obviousness Reasoning
The original patent's encapsulation strategy provides a predictable method for controlled biological agent deployment, making agricultural pest management an obvious extension of the core technological concept
Source Patent Element
Biocompatible metallic device capable of local and systemic agent diffusion
PTD Variation
Adapting the nanoporous canister for cosmetic and skincare applications promoting tissue regeneration
Obviousness Reasoning
A PHOSITA would understand that the original patent's focus on tissue repair and controlled biological factor release directly translates to skincare regeneration technologies
Source Patent Element
Nanoscale structure enabling isolation and controlled release of cellular/biotherapeutic factors
PTD Variation
Implementing nanoporous canisters for bioremediation with metabolically active microorganisms
Obviousness Reasoning
The patent's core mechanism of contained biological agent deployment represents a finite, predictable solution for introducing targeted microorganisms into environmental systems
35 U.S.C. § 103 Summary: Based on US Patent 11857672's disclosure of a nanoporous implantable device for controlled biological agent release, the present publication demonstrates that variations applying this fundamental technological approach to environmental monitoring, agricultural pest control, cosmetic applications, and bioremediation would have been obvious to a person having ordinary skill in the art at the time of invention, thereby establishing anticipatory prior art against potential future patent claims in these domains.

Original Patent Information

Patent NumberUS 11,857,672
TitleImplantable cellular and biotherapeutic agent delivery canister
Assignee(s)NanoVault Medical LLC